THC: Tenet Healthcare Corporation Stock

by  •  • Comments Off on THC: Tenet Healthcare Corporation Stock

SIC 8062 – General Medical and Surgical Hospitals

Valuation
Market Cap ($M) 11,931.98
Enterprise Value ($M) 26,461.98
Book Value ($M) 8,547.00
Book Value / Share 89.85
Price / Book 1.40
NCAV ($M) -12,707.00
NCAV / Share -133.59
Price / NCAV -0.94

Profitability (mra)
Return on Invested Capital (ROIC) 0.14
Return on Assets (ROA) 0.11
Return on Equity (ROE) 0.58

Liquidity (mrq)
Quick Ratio 1.70
Current Ratio 1.78

Balance Sheet (mrq) ($M)
Current Assets 7,682.00
Assets 28,936.00
Liabilities 20,389.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 20,665.00
Operating Income 2,907.00
Net Income 3,200.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 2,047.00
Cash from Investing 3,429.00
Cash from Financing -3,685.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Price T Rowe Associates Inc /md/ 7.80 4.72
11-14 13G/A Glenview Capital Management, Llc 2.77 -65.66
11-12 13G Fmr Llc 8.04 70.58
2024-02-15 13G Lind Global Fund II LP 9.90
2024-02-14 13G/A Harris Associates L P 0.00 -99.93
2024-02-13 13G/A Vanguard Group Inc 10.94 -1.71
2024-02-09 13G Invesco Ltd. 5.30 29.82

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ý Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2024 OR ¨ Transition report pursuant to Sect
2024-10-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2024 OR ¨ Transition report pursuan
2024-07-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2024 OR ¨ Transition report pursuant to
2024-04-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2024 OR ¨ Transition report pursuant to

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 327,513 1,124,275 29.13
2025-03-06 395,810 1,350,093 29.32
2025-03-05 280,707 1,040,700 26.97
2025-03-04 493,198 1,644,626 29.99
2025-03-03 346,166 1,486,971 23.28

(click for more detail)

Similar Companies
HCA – HCA Healthcare, Inc. MD – Pediatrix Medical Group, Inc.
SEM – Select Medical Holdings Corporation


Financial data and stock pages provided by
Fintel.io